{
    "items": "123",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Futures: Five Stocks In Buy Areas",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-future-5-stocks-in-buy-areas-as-market-rally-powers-higher/",
            "time_published": "20240204T152900",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Futures: 5 Stocks In Buy Areas As Rally Powers Higher Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/09/Stock-BullHead-91-adobe-1.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.967321"
                }
            ],
            "overall_sentiment_score": 0.065161,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.022946",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.162718",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.056491",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.130352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.14785",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXON",
                    "relevance_score": "0.022243",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDB",
                    "relevance_score": "0.11087",
                    "ticker_sentiment_score": "0.082417",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.022243",
                    "ticker_sentiment_score": "0.025406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.11087",
                    "ticker_sentiment_score": "-0.011089",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.130352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.176502",
                    "ticker_sentiment_score": "-0.137966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.11087",
                    "ticker_sentiment_score": "-0.106411",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.18076",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNPS",
                    "relevance_score": "0.132855",
                    "ticker_sentiment_score": "0.025322",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.18076",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.18076",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMG",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.18076",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "0.105074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "-0.019266",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures: 5 Stocks In Buy Areas As Rally Powers Higher",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-future-5-stocks-in-buy-areas-as-market-rally-powers-higher/",
            "time_published": "20240204T135800",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Market Powers To Highs Despite This. 5 New Stocks In Buy Areas Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/09/Stock-BullHead-91-adobe-1.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                }
            ],
            "overall_sentiment_score": 0.100894,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.023007",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.169832",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.15957",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.130999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXON",
                    "relevance_score": "0.026127",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDB",
                    "relevance_score": "0.130076",
                    "ticker_sentiment_score": "0.088441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.026127",
                    "ticker_sentiment_score": "0.025975",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.130076",
                    "ticker_sentiment_score": "-0.011893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.130999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.155786",
                    "ticker_sentiment_score": "-0.208682",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.136554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.136554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNPS",
                    "relevance_score": "0.155786",
                    "ticker_sentiment_score": "0.02778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.136554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.136554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMG",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.136554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.078269",
                    "ticker_sentiment_score": "0.107195",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Earnings, Jobs, And The Magnificent 7 Soar",
            "url": "https://www.forbes.com/sites/bill_stone/2024/02/04/earnings-jobs-and-the-magnificent-7-soar/",
            "time_published": "20240204T120000",
            "authors": [
                "Bill Stone"
            ],
            "summary": "Last week was the busiest of earnings season, with 106 S&P 500 companies reporting. The S&P 500 rose 1.4% for the week, driven primarily by earnings and the Magnificent 7. The 10-year Treasury yield was fractionally lower at 4.0%.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65be6a5b3de8507b84cf569c/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.928139"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99998"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.198921,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "0.320847",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "0.320847",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "0.212136",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "0.306357",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "0.212136",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.056943",
                    "ticker_sentiment_score": "-0.198994",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.22152",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.22152",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.22152",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "After a 90% Gain, Is It Too Late to Buy Eli Lilly?",
            "url": "https://www.fool.com/investing/2024/02/04/after-a-90-gain-is-it-too-late-to-buy-eli-lilly/",
            "time_published": "20240204T090500",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F763686%2Fgettyimages-903626078.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.236494,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.055236",
                    "ticker_sentiment_score": "0.04908",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.554014",
                    "ticker_sentiment_score": "0.356177",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.164656",
                    "ticker_sentiment_score": "0.052794",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Disney, Caterpillar, McDonald's, Ford: Investing Action Plan",
            "url": "https://www.investors.com/research/investing-action-plan/disney-stock-caterpillar-mcdonalds-ford-investing-action-plan/",
            "time_published": "20240202T230000",
            "authors": [
                "ALAN R. ELLIOTT",
                "Investor's Business Daily"
            ],
            "summary": "Disney Stock, Caterpillar, McDonald's, Ford: Investing Action Plan Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/01/stock-NYSE-05-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998356"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.115657,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "-0.065969",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TENB",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.021495",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.026981",
                    "ticker_sentiment_score": "0.028291",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.094",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "-0.017985",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NXPI",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.070764",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDB",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.098148",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPG",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.065573",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.030931",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LITE",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "-0.046811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.091947",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEN",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.098148",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCK",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.141",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FTNT",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.020982",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORLY",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.007181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.134289",
                    "ticker_sentiment_score": "0.074545",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ENB",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.027839",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.0255",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNPS",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.098148",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GLOB",
                    "relevance_score": "0.080819",
                    "ticker_sentiment_score": "0.098148",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.11074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TTWO",
                    "relevance_score": "0.053931",
                    "ticker_sentiment_score": "0.05579",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P 500 Hits High In Stock Picker's Market; Five New Buys",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-hit-highs-stock-pickers-market-5-new-buys-tesla-leads-losers/",
            "time_published": "20240202T224900",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "S&P 500 Hits High In Stock Picker's Market. Five New Buys Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/09/Stock-BullHead-91-adobe-1.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                }
            ],
            "overall_sentiment_score": 0.098442,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.023029",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.109455",
                    "ticker_sentiment_score": "0.172706",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.159857",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.13103",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXON",
                    "relevance_score": "0.027445",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDB",
                    "relevance_score": "0.136577",
                    "ticker_sentiment_score": "0.09451",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.027445",
                    "ticker_sentiment_score": "0.026153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.109455",
                    "ticker_sentiment_score": "-0.015541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.13103",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.163539",
                    "ticker_sentiment_score": "-0.215236",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.136835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.136835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNPS",
                    "relevance_score": "0.163539",
                    "ticker_sentiment_score": "0.030049",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.136835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.136835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMG",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.136835",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Stock Reports for Eli Lilly, Danaher & Citigroup",
            "url": "https://www.zacks.com/research-daily/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup",
            "time_published": "20240202T215900",
            "authors": [
                "Mark Vickery"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/af/51929.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.260398,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.298264",
                    "ticker_sentiment_score": "0.202381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.158795",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABCZF",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.183981",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.298264",
                    "ticker_sentiment_score": "0.097043",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "A Closer Look At The Disruption Of Medifast",
            "url": "https://www.forbes.com/sites/gurufocus/2024/02/02/a-closer-look-at-the-disruption-of-medifast/",
            "time_published": "20240202T173126",
            "authors": [
                "GuruFocus"
            ],
            "summary": "The weight loss and nutrition product company is coping with the GLP-1 drug tsunami • The new diabetes and diet drugs appear to have disrupted the company's extremely profitable business model. Weight loss and wellness product company Medifast Inc. ( MED, Financial ) has experienced a significant ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65bd2469f0bee498c099bcba/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.098847,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.069294",
                    "ticker_sentiment_score": "-0.170101",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LFMD",
                    "relevance_score": "0.03468",
                    "ticker_sentiment_score": "-0.012375",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VALU",
                    "relevance_score": "0.03468",
                    "ticker_sentiment_score": "-0.163211",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MED",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.10894",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.069294",
                    "ticker_sentiment_score": "-0.170101",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "What's Going On With Eli Lilly Stock Today? - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/02/36913823/whats-going-on-with-eli-lilly-stock-today",
            "time_published": "20240202T172909",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY is set to announce its fourth quarter 2023 financial results next week on Tuesday, 6 February. The analysts expect Eli Lilly to report $2.19 per share earnings and sales of $8.932 billion, according to data from Benzinga Pro.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Eli-Lilly_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": -0.009466,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.817578",
                    "ticker_sentiment_score": "0.163751",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "ELF Beauty, Palantir, Arm Holdings, Chipotle Headline Busy Earnings Calendar",
            "url": "https://www.investors.com/research/earnings-preview/earnings-calendar-spotlight-sellers-hit-palantir-stock-growth-concerns/",
            "time_published": "20240202T163900",
            "authors": [
                "KEN SHREVE",
                "Investor's Business Daily"
            ],
            "summary": "Earnings Calendar Spotlight: Sellers Hit Palantir Stock Amid Growth Concerns. Expectations High For ELF Beauty Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/02/EARNwatch020524.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.148699,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "-0.084032",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.192228",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.03157",
                    "ticker_sentiment_score": "-0.078621",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.106054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.106054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.094514",
                    "ticker_sentiment_score": "0.099503",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMG",
                    "relevance_score": "0.156868",
                    "ticker_sentiment_score": "0.106841",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NET",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.106054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBNY",
                    "relevance_score": "0.03157",
                    "ticker_sentiment_score": "-0.18159",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "APOS",
                    "relevance_score": "0.03157",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NYCB",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "-0.188672",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "4 Large Drug Stocks Trying to Survive the Industry Challenges",
            "url": "https://www.zacks.com/commentary/2220023/4-large-drug-stocks-trying-to-survive-the-industry-challenges",
            "time_published": "20240202T134700",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), AbbVie (ABBV) and Novartis (NVS) are worth retaining in one's portfolio.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/85/906.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.215569,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.235366",
                    "ticker_sentiment_score": "0.15857",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.023885",
                    "ticker_sentiment_score": "0.065458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.189298",
                    "ticker_sentiment_score": "0.236489",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.118999",
                    "ticker_sentiment_score": "0.140653",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.023885",
                    "ticker_sentiment_score": "0.065458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.023885",
                    "ticker_sentiment_score": "0.031019",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AbbVie  ( ABBV )  Q4 Earnings and Revenues Top Estimates",
            "url": "https://www.zacks.com/stock/news/2220125/abbvie-abbv-q4-earnings-and-revenues-top-estimates",
            "time_published": "20240202T134502",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "AbbVie (ABBV) delivered earnings and revenue surprises of 1.09% and 1.78%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default188.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999997"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.16185,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.139669",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.402403",
                    "ticker_sentiment_score": "0.208814",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Market Whales and Their Recent Bets on LLY Options - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/insights/options/24/02/36889771/market-whales-and-their-recent-bets-on-lly-options",
            "time_published": "20240201T144710",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.002398,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.764792",
                    "ticker_sentiment_score": "-0.102214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.085936",
                    "ticker_sentiment_score": "-0.104834",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.085936",
                    "ticker_sentiment_score": "-0.131693",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly  ( LLY )  Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
            "url": "https://www.zacks.com/stock/news/2219391/lilly-lly-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures",
            "time_published": "20240201T141522",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default45.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.126879,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.359707",
                    "ticker_sentiment_score": "0.224852",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Topped the Market Today",
            "url": "https://www.fool.com/investing/2024/01/31/why-eli-lilly-stock-topped-the-market-today/",
            "time_published": "20240131T231600",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "One of its more recently approved drugs will be launched into a white-hot market.",
            "banner_image": "https://g.foolcdn.com/editorial/images/763435/patient-and-physician-smiling-during-a-visit.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.265184,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.614086",
                    "ticker_sentiment_score": "0.456209",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.512093",
                    "ticker_sentiment_score": "0.509193",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  to Report Q4 Earnings: What's in the Cards?",
            "url": "https://www.zacks.com/stock/news/2218932/eli-lilly-lly-to-report-q4-earnings-whats-in-the-cards",
            "time_published": "20240131T164800",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "On Eli Lilly's (LLY) fourth-quarter conference call, investor focus is likely to be on the sales performance of its tirzepatide medicines, Mounjaro and Zepbound.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99998"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                }
            ],
            "overall_sentiment_score": 0.138198,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.400691",
                    "ticker_sentiment_score": "0.13284",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.207216",
                    "ticker_sentiment_score": "0.058657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.207216",
                    "ticker_sentiment_score": "0.047535",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.207216",
                    "ticker_sentiment_score": "-0.001617",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It",
            "url": "https://www.zacks.com/stock/news/2218601/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it",
            "time_published": "20240131T140010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default286.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.219612,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.528798",
                    "ticker_sentiment_score": "0.154158",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Biogen drops controversial Alzheimer's drug",
            "url": "https://www.marketwatch.com/story/biogen-halts-development-of-controversial-alzheimers-drug-3e03858a",
            "time_published": "20240131T135900",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Biogen is halting the development and commercialization of the Alzheimer's drug Aduhelm, which drew intense scrutiny of its U.S. regulatory process due to concerns about whether its benefits outweighed its risks.",
            "banner_image": "https://images.mktw.net/im-17279099/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.12517,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.186738",
                    "ticker_sentiment_score": "0.272324",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.712214",
                    "ticker_sentiment_score": "0.193001",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares - AstraZeneca  ( NASDAQ:AZN ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36866023/take-your-ozempic-why-late-entry-of-rival-weight-loss-drugs-wont-floor-novo-eli-sha",
            "time_published": "20240131T134944",
            "authors": [
                "Neil Dennis"
            ],
            "summary": "Eli Lilly LLY reports its fourth quarter earnings next week and, as Novo Nordisk NVO did on Wednesday, is expected to wow investors with earnings and revenue beats thanks, in large part, to the overwhelming success of its diabetes treatments that have become popular weight-loss solutions.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/ozempic-shutter.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.187068,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "0.249005",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "-0.039113",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PTAIF",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.119694",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "0.289771",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "0.262369",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "0.092059",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ozempic maker Novo Nordisk reports 62% surge in profit",
            "url": "https://www.marketwatch.com/story/ozempic-maker-novo-nordisk-reports-62-surge-in-profit-584a5064",
            "time_published": "20240131T085200",
            "authors": [
                "Steve Goldstein"
            ],
            "summary": "Novo Nordisk on Wednesday said its fourth-quarter profit surged by nearly two-thirds, driven by the popularity of its weight-loss drugs that have made it Europe's largest company.",
            "banner_image": "https://images.mktw.net/im-809249/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.239467,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "-0.059165",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.746902",
                    "ticker_sentiment_score": "0.417184",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.038291",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Earnings Expected to Grow: Should You Buy?",
            "url": "https://www.zacks.com/stock/news/2217983/eli-lilly-lly-earnings-expected-to-grow-should-you-buy",
            "time_published": "20240130T150056",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default302.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.149619,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.259727",
                    "ticker_sentiment_score": "0.127026",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.174903",
                    "ticker_sentiment_score": "-0.001424",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Lilly  ( LLY )  a Buy as Wall Street Analysts Look Optimistic?",
            "url": "https://www.zacks.com/stock/news/2217883/is-lilly-lly-a-buy-as-wall-street-analysts-look-optimistic",
            "time_published": "20240130T143006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "According to the average brokerage recommendation (ABR), one should invest in Lilly (LLY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
            "banner_image": "https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/LLY_01302024.png",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.459462"
                }
            ],
            "overall_sentiment_score": 0.283192,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.362254",
                    "ticker_sentiment_score": "0.180653",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Beam Therapeutics Stock Zoomed 17% Higher Today",
            "url": "https://www.fool.com/investing/2024/01/29/why-beam-therapeutics-stock-zoomed-17-higher-today/",
            "time_published": "20240129T232100",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "JPMorgan Chase becomes the latest institution in the company's bull pen.",
            "banner_image": "https://g.foolcdn.com/editorial/images/763126/person-in-a-lab-looking-through-a-microscope.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.226592,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BEAM",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.314666",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.142565",
                    "ticker_sentiment_score": "0.162916",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Beats Stock Market Upswing: What Investors Need to Know",
            "url": "https://www.zacks.com/stock/news/2217450/eli-lilly-lly-beats-stock-market-upswing-what-investors-need-to-know",
            "time_published": "20240129T224519",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) concluded the recent trading session at $645, signifying a +0.9% move from its prior day's close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default37.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.917436"
                }
            ],
            "overall_sentiment_score": 0.20128,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.598621",
                    "ticker_sentiment_score": "0.27535",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly Wants to Expand Access to Weight-Loss Treatments In Germany, In Talks With Government - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36830456/eli-lilly-wants-to-expand-access-to-weight-loss-treatments-in-germany-in-talks-with-government",
            "time_published": "20240129T181423",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY is reportedly engaged in discussions with the German government to lift the ban on the public health system covering the costs of weight-loss treatments.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.053268,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.59016",
                    "ticker_sentiment_score": "0.038645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "0.15576",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "We're calling up a health care stock from our Bullpen watch list, starting a new position",
            "url": "https://www.cnbc.com/2024/01/29/were-calling-up-a-health-care-stock-from-our-bullpen-watch-list-starting-a-new-position.html",
            "time_published": "20240129T140341",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Now that expectations have cooled down, we think this pullback is one worth buying.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107250871-1685970222341-gettyimages-1258453480-Port_Trade_Growth_In_Lianyungang.jpeg?v=1698261998&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.96136"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.905476"
                }
            ],
            "overall_sentiment_score": 0.209243,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.074809",
                    "ticker_sentiment_score": "0.090625",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.037446",
                    "ticker_sentiment_score": "0.087033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.153796",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "How to Find Strong Medical Stocks Slated for Positive Earnings Surprises",
            "url": "https://www.zacks.com/stock/news/2216951/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises",
            "time_published": "20240129T135006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default283.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999989"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.371141,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.392948",
                    "ticker_sentiment_score": "0.333286",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "How Is The Market Feeling About Eli Lilly? - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/insights/short-sellers/24/01/36823514/how-is-the-market-feeling-about-eli-lilly",
            "time_published": "20240129T133016",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly's LLY short percent of float has fallen 3.12% since its last report. The company recently reported that it has 4.89 million shares sold short, which is 0.62% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.47 days to cover their ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.237023,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.081322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Await Huge Market News",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-microsoft-leads-huge-earnings-wave/",
            "time_published": "20240129T131000",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Futures: Microsoft Leads Huge Earnings Wave Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/04/Stock-BigWavePipe-08-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                }
            ],
            "overall_sentiment_score": 0.128441,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.450828",
                    "ticker_sentiment_score": "0.05364",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.235442",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "-0.178319",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "0.004122",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.273224",
                    "ticker_sentiment_score": "0.063015",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.079524",
                    "ticker_sentiment_score": "-0.178319",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.119038",
                    "ticker_sentiment_score": "-0.043251",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.235442",
                    "ticker_sentiment_score": "0.001774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.235442",
                    "ticker_sentiment_score": "0.029396",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.119038",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.158259",
                    "ticker_sentiment_score": "0.001322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Buy in 2024: The \"Magnificent Seven\" or the \"Terrific 10\"?",
            "url": "https://www.fool.com/investing/2024/01/29/better-buy-the-magnificent-seven-or-terrific-ten/",
            "time_published": "20240129T112600",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "The financial and healthcare sectors make up a massive amount of the market.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762431%2Fgettyimages-1419726675-1201x633-65d4be6.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999956"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.857896"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.333127,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.101721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.122273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.201917",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.120472",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.137474",
                    "ticker_sentiment_score": "0.163389",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.111863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.271149",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.101721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.122273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.171363",
                    "ticker_sentiment_score": "0.256013",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.03453",
                    "ticker_sentiment_score": "0.103812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.068995",
                    "ticker_sentiment_score": "0.144218",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.137474",
                    "ticker_sentiment_score": "0.127343",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.238133",
                    "ticker_sentiment_score": "0.303144",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.171363",
                    "ticker_sentiment_score": "0.277563",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Want to Get Richer in 2024? 2 Top Stocks to Buy Now",
            "url": "https://www.fool.com/investing/2024/01/29/want-to-get-richer-in-2024-2-top-stocks-to-buy-now/",
            "time_published": "20240129T101500",
            "authors": [
                "Joe Tenebruso"
            ],
            "summary": "Both of these companies have revenue drivers to keep the growth going.",
            "banner_image": "https://media.ycharts.com/charts/3229c5917109536bc38e882a3833c516.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.290036,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.06697",
                    "ticker_sentiment_score": "-0.099573",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.199037",
                    "ticker_sentiment_score": "-0.049216",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.325637",
                    "ticker_sentiment_score": "0.410488",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "2 Unstoppable Stocks to Buy and Hold For at Least 10 Years",
            "url": "https://www.fool.com/investing/2024/01/29/2-unstoppable-stocks-to-buy-and-hold-for-at-least/",
            "time_published": "20240129T082900",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "It's hard to bet against these companies right now.",
            "banner_image": "https://g.foolcdn.com/editorial/images/762585/patient-talking-with-a-physician.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.372593,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.484697",
                    "ticker_sentiment_score": "0.428275",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.573492",
                    "ticker_sentiment_score": "0.557749",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.232005",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Monthly Meeting Q&A with Jim Cramer: Everything from health care to industrials to portfolio management",
            "url": "https://www.cnbc.com/2024/01/28/monthly-meeting-qa-with-jim-cramer-everything-from-health-care-to-industrials.html",
            "time_published": "20240128T180102",
            "authors": [
                "Paulina Likos"
            ],
            "summary": "During the January Monthly Meeting, we took questions directly from Investing Club members.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107200470-1677528554271-NUP_200782_00237.jpg?v=1697057003&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928139"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.07939,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.019086",
                    "ticker_sentiment_score": "0.029932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DKNG",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.033849",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.032468",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.033849",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIDU",
                    "relevance_score": "0.019086",
                    "ticker_sentiment_score": "0.029932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WYNN",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.032468",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.032468",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "0.033046",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.019086",
                    "ticker_sentiment_score": "0.029932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.189076",
                    "ticker_sentiment_score": "0.051361",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "0.033046",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ETN",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.033849",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTRA",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "0.033046",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.032468",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Forget The Magnificent Seven. Focus On These Fab Five.",
            "url": "https://www.investors.com/news/sp-500-forget-magnificent-seven-focus-on-fab-five/",
            "time_published": "20240128T130000",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "The Magnificent Seven stocks - S&P 500 giants Amazon.com ( AMZN ) , Apple ( AAPL ) , Google parent Alphabet ( GOOGL ) , Meta Platforms ( META ) , Microsoft ( MSFT ) , Nvidia ( NVDA ) and Tesla ( TSLA ) - have been grouped together since the start of the bull market in January 2023.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/11/Stock-AImachinelearning-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.181552,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.321927",
                    "ticker_sentiment_score": "0.294393",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.060161",
                    "ticker_sentiment_score": "-0.1661",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "0.218425",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.526614",
                    "ticker_sentiment_score": "0.312372",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.265859",
                    "ticker_sentiment_score": "0.210761",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNPR",
                    "relevance_score": "0.060161",
                    "ticker_sentiment_score": "0.107001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.060161",
                    "ticker_sentiment_score": "0.100001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADM",
                    "relevance_score": "0.060161",
                    "ticker_sentiment_score": "-0.1661",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.176881",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.40271",
                    "ticker_sentiment_score": "0.274766",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.321927",
                    "ticker_sentiment_score": "0.083558",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "-0.081834",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "0.185532",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.294093",
                    "ticker_sentiment_score": "0.246411",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.060161",
                    "ticker_sentiment_score": "-0.1661",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "If You Invested $5,000 in Novo Nordisk in 2019, This Is How Much You Would Have Today",
            "url": "https://www.fool.com/investing/2024/01/27/if-you-invested-5000-in-novo-nordisk-in-2019/",
            "time_published": "20240127T160000",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "The answer may surprise you.",
            "banner_image": "https://media.ycharts.com/charts/67ec276a6508aaf6afdc910fd4bcc2bb.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.280356,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "-0.01712",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.748842",
                    "ticker_sentiment_score": "0.459995",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Could Eli Lilly Be a Trillion-Dollar Company by 2030?",
            "url": "https://www.fool.com/investing/2024/01/27/could-eli-lilly-be-a-trillion-dollar-company-by-20/",
            "time_published": "20240127T132500",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Eli Lilly is the world's largest healthcare company by market cap, and the 10th most valuable business in the world.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762341%2Fdoctor-showing-patient-a-chart.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.986714"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.305641,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.766317",
                    "ticker_sentiment_score": "0.468276",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.090304",
                    "ticker_sentiment_score": "0.097646",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Earnings Tsunami Looms For Market Rally; Seven Stocks To Watch",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-earnings-tsunami-looms-microsoft-apple-lead-7-stocks-to-watch/",
            "time_published": "20240126T214100",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Futures: Earnings Tsunami Looms. Microsoft, Apple Lead 7 Stocks To Watch Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/04/Stock-BigWavePipe-08-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                }
            ],
            "overall_sentiment_score": 0.121082,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.443626",
                    "ticker_sentiment_score": "0.090942",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.210823",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.085173",
                    "ticker_sentiment_score": "-0.180785",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.085173",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.291842",
                    "ticker_sentiment_score": "0.108265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.085173",
                    "ticker_sentiment_score": "-0.180785",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.085173",
                    "ticker_sentiment_score": "-0.180785",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.25168",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.25168",
                    "ticker_sentiment_score": "0.030817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.169378",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "We Might Have Sold But This Stock Still Deserves Attention",
            "url": "https://www.investors.com/research/swing-trading/short-moves-in-eli-lilly-stock-good-for-swing-trading/",
            "time_published": "20240126T211200",
            "authors": [
                "Investor's Business Daily",
                "JUSTIN NIELSEN"
            ],
            "summary": "Eli Lilly Stock Still Deserves Attention Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/wSWING012924.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                }
            ],
            "overall_sentiment_score": 0.159895,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.608634",
                    "ticker_sentiment_score": "0.174729",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/insights/options/24/01/36802049/eli-lilly-unusual-options-activity",
            "time_published": "20240126T144602",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.026409,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.769861",
                    "ticker_sentiment_score": "0.00799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "-0.131944",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "-0.105032",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tesla's Market Cap Dips Below Eli Lilly Following Q4 Revenue Miss: Report - Tesla  ( NASDAQ:TSLA ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/24/01/36794521/teslas-market-cap-dips-below-eli-lilly-following-q4-revenue-miss-report",
            "time_published": "20240126T005853",
            "authors": [
                "Benzinga Neuro"
            ],
            "summary": "Tesla Inc. TSLA has been surpassed in market value by pharmaceutical giant Eli Lilly LLY, following a 12% single-day plunge in Tesla's stock. What Happened: Tesla's fourth-quarter earnings report, which fell short of revenue and profit expectations, triggered a significant drop in its stock price.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/NeuroImage_0.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.117845,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.328455",
                    "ticker_sentiment_score": "0.140541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.328455",
                    "ticker_sentiment_score": "0.161825",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.084423",
                    "ticker_sentiment_score": "0.048427",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.084423",
                    "ticker_sentiment_score": "-0.208128",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Eli Lilly's Famed Obesity And Diabetes Drug, Mounjaro, Comes To UK Patients, Wins Regulatory Clearance For Prefilled Injection Pen - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36790349/eli-lillys-famed-obesity-and-diabetes-drug-mounjaro-comes-to-uk-patients-wins-regulatory-clearanc",
            "time_published": "20240125T211159",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "The Medicines and Healthcare products Regulatory Agency ( MHRA ) has approved, Thursday, a four-dose version of the diabetes and weight management medicine Mounjaro ( tirzepatide ) . Eli Lilly And Co's LLY Mounjaro will be branded as Mounjaro KwikPen in the U.K.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.181265,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.47672",
                    "ticker_sentiment_score": "0.132125",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.250386",
                    "ticker_sentiment_score": "0.064744",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johna Norton to Retire as Lilly Executive Vice President of Global Quality",
            "url": "https://www.prnewswire.com/news-releases/johna-norton-to-retire-as-lilly-executive-vice-president-of-global-quality-302043876.html",
            "time_published": "20240125T130000",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Jan. 25, 2024 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced that Johna Norton, executive vice president of Global Quality, will be retiring after 34 years of service with the company, effective July 31, 2024.",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.196394,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.452639",
                    "ticker_sentiment_score": "0.230674",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CURN",
                    "relevance_score": "0.034282",
                    "ticker_sentiment_score": "0.005853",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.034282",
                    "ticker_sentiment_score": "0.138739",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AKUS",
                    "relevance_score": "0.034282",
                    "ticker_sentiment_score": "0.134834",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight Loss Drug's Ozempic Counterfeit: Rising Reports Over Patient Safety Related Fake Drugs - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36765784/weight-loss-drugs-ozempic-counterfeit-rising-reports-over-patient-safety-related-fake-drugs",
            "time_published": "20240124T192152",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Three individuals sought medical attention for dangerously low blood sugar in the U.S. in the previous year, having taken suspected fake versions of Novo Nordisk A/S's NVO diabetes medication, Ozempic ( semaglutide ) , according to the American Association of Poison Control Centers ( AAPCC ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/OZempic-Insulin.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.316647,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "-0.163204",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.56217",
                    "ticker_sentiment_score": "-0.381676",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        },
        {
            "title": "Stock Of The Day Lilly Is In A Buy Zone. And It's Not Related To Obesity.",
            "url": "https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-rallies-into-buy-zone-on-surprising-results-in-treating-deafness/",
            "time_published": "20240124T171200",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "Eli Lilly Stock Rallies Into Buy Zone On Surprising Results In Treating Deafness Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/SOTD-1-24-2024LLY.png",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.053361,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.55533",
                    "ticker_sentiment_score": "0.145116",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AKUS",
                    "relevance_score": "0.151539",
                    "ticker_sentiment_score": "0.063005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.151539",
                    "ticker_sentiment_score": "-0.049141",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.101367",
                    "ticker_sentiment_score": "-0.043919",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/insights/options/24/01/36759493/eli-lilly-unusual-options-activity",
            "time_published": "20240124T144708",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.011968,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.737428",
                    "ticker_sentiment_score": "-0.119866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "-0.117744",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Abbott Labs' fourth-quarter sales top estimates amid strong medical-device demand",
            "url": "https://www.marketwatch.com/story/abbott-labs-fourth-quarter-sales-top-estimates-amid-strong-medical-device-demand-4d68669e",
            "time_published": "20240124T125700",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Abbott Laboratories on Wednesday reported fourth-quarter sales that topped expectations amid strength in its medical-device and nutrition segments.",
            "banner_image": "https://images.mktw.net/im-549400/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.162117,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.197008",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TNDM",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.111972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.148273",
                    "ticker_sentiment_score": "0.006598",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Stock Sinks As Market Gains: Here's Why",
            "url": "https://www.zacks.com/stock/news/2214575/eli-lilly-lly-stock-sinks-as-market-gains-heres-why",
            "time_published": "20240123T224518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The latest trading day saw Eli Lilly (LLY) settling at $629.68, representing a -0.19% change from its previous close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default314.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.191838,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.565003",
                    "ticker_sentiment_score": "0.229546",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly gene therapy allows child born deaf to hear, clinical trial shows",
            "url": "https://www.marketwatch.com/story/eli-lilly-gene-therapy-allows-child-born-deaf-to-hear-clinical-trial-shows-e66d55be",
            "time_published": "20240123T180600",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "An Eli Lilly experimental gene therapy has restored the hearing of a child who was born deaf.",
            "banner_image": "https://images.mktw.net/im-735118/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.128958,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.678673",
                    "ticker_sentiment_score": "0.216414",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AKUS",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "-0.020406",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These 2 Growth Stocks Are Brilliant Buys for the New Year",
            "url": "https://www.fool.com/investing/2024/01/23/these-2-growth-stocks-are-brilliant-buys-for-the/",
            "time_published": "20240123T144500",
            "authors": [
                "Rachel Warren"
            ],
            "summary": "Business is booming for these stocks, and investors might want to stop and take note.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761836/family-cuddling-on-sofa-at-home.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.94762"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.260007,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.247418",
                    "ticker_sentiment_score": "0.258839",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TRMNF",
                    "relevance_score": "0.041901",
                    "ticker_sentiment_score": "0.122225",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.28696",
                    "ticker_sentiment_score": "0.271791",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?",
            "url": "https://www.zacks.com/stock/news/2213920/should-you-invest-in-the-ishares-us-healthcare-etf-iyh",
            "time_published": "20240123T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.221904,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.066784",
                    "ticker_sentiment_score": "0.088171",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.069906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.069906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.069906",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?",
            "url": "https://www.zacks.com/stock/news/2213924/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv",
            "time_published": "20240123T112005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default19.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.2573,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.063784",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.127397",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.089059",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.063784",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.063784",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Monster Stocks to Buy Without Any Hesitation",
            "url": "https://www.fool.com/investing/2024/01/23/2-monster-stocks-to-buy-without-any-hesitation/",
            "time_published": "20240123T110000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These stocks both could deliver great rewards over time.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762141%2Fgettyimages-468679176.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99246"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.321362,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.551295",
                    "ticker_sentiment_score": "0.204225",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "0.065101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.53287",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.013032",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Don't Be Fooled by These 3 Misleading Facts About Eli Lilly Stock",
            "url": "https://www.fool.com/investing/2024/01/23/3-misleading-facts-about-eli-lilly-stock/",
            "time_published": "20240123T065900",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "Don't let a few disparate facts dominate your view of this company.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761493/investor-considers-papers-while-sitting-near-books.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.007331,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.312158",
                    "ticker_sentiment_score": "-0.120877",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Jim Cramer Says Eli Lilly Could Replace Tesla In 'Magnificent Seven' List: 'To Ignore...Is To Reject The Facts' - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",
            "url": "https://www.benzinga.com/markets/equities/24/01/36729974/jim-cramer-says-eli-lilly-could-replace-tesla-in-magnificent-seven-list-to-ignore-is-to-reject-t",
            "time_published": "20240123T030212",
            "authors": [
                "Benzinga Neuro"
            ],
            "summary": "Jim Cramer, the host of CNBC's \"Mad Money,\" has hinted at the possibility of Tesla Inc TSLA being replaced by Eli Lilly and Co LLY in the \"Magnificent Seven\" list of mega-cap stocks.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Jim-Cramer-Photo-by-s-bukley-on-Shutters_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.132447,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.24853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.24853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.24853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.24853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.24853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.589793",
                    "ticker_sentiment_score": "0.050007",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "-0.151246",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.254895",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.589793",
                    "ticker_sentiment_score": "0.144922",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HTZ",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "-0.151246",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/insights/news/24/01/36720412/if-you-invested-100-in-this-stock-20-years-ago-you-would-have-900-today",
            "time_published": "20240122T173044",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly LLY has outperformed the market over the past 20 years by 4.2% on an annualized basis producing an average annual return of 11.72%. Currently, Eli Lilly has a market capitalization of $598.54 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.158543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.980595",
                    "ticker_sentiment_score": "0.375984",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "These 5 Wildly Popular High-Flying Stocks of 2023 Could Be Duds in the Rest of 2024, According to Wall Street",
            "url": "https://www.fool.com/investing/2024/01/22/these-5-wildly-popular-high-flying-stocks-of-2023/",
            "time_published": "20240122T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Analysts have not-so-great expectations going forward for these huge winners.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761848/young-woman-frustrated-laptop.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.459462"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.182612,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "0.124941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.310843",
                    "ticker_sentiment_score": "0.138121",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.088872",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.268294",
                    "ticker_sentiment_score": "0.102004",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.268294",
                    "ticker_sentiment_score": "0.25253",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Prediction: This Will Be the First Trillion-Dollar Healthcare Stock",
            "url": "https://www.fool.com/investing/2024/01/21/prediction-this-will-be-the-first-trillion-dollar/",
            "time_published": "20240121T160200",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "This company is currently firing on all cylinders.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761056/doctor-with-patient-talking.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.267579,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.637818",
                    "ticker_sentiment_score": "0.397667",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.220809",
                    "ticker_sentiment_score": "0.191225",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.220809",
                    "ticker_sentiment_score": "0.213931",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.166551",
                    "ticker_sentiment_score": "0.132619",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is It Too Late to Buy Eli Lilly Stock?",
            "url": "https://www.fool.com/investing/2024/01/21/is-it-too-late-to-buy-crispr-therapeutics-stock/",
            "time_published": "20240121T153000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Eli Lilly is now the most valuable healthcare stock in the world.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761255/a-doctor-looking-at-a-tablet-with-another-person.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.212301,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.666827",
                    "ticker_sentiment_score": "0.366365",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "SGTX",
                    "relevance_score": "0.055109",
                    "ticker_sentiment_score": "0.131851",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.055109",
                    "ticker_sentiment_score": "0.080989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.055109",
                    "ticker_sentiment_score": "0.131851",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "24 Dividend Growth Stocks to Buy and Hold in 2024",
            "url": "https://www.fool.com/investing/2024/01/21/24-dividend-growth-stocks-to-buy-and-hold-in-2024/",
            "time_published": "20240121T105100",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Dividends are good. Growing dividends are even better.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761751/excited-investor-looks-at-financial-charts-on-computer.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.360211,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IIPR",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.140815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.153863",
                    "ticker_sentiment_score": "0.303904",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.061869",
                    "ticker_sentiment_score": "0.190566",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.092688",
                    "ticker_sentiment_score": "0.175204",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.391015",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.141351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.225235",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.141351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.061869",
                    "ticker_sentiment_score": "0.127185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.391015",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Here's What Investors Should Expect From Eli Lilly Stock in 2024",
            "url": "https://www.fool.com/investing/2024/01/20/heres-what-investors-should-expect-from-eli-lilly/",
            "time_published": "20240120T212900",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "More headlines on the horizon.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761474/investors-watch-a-presentation-around-a-table.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.243767,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.544246",
                    "ticker_sentiment_score": "0.335515",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.110251",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Will Eli Lilly Be Worth More Than Meta Platforms by 2030?",
            "url": "https://www.fool.com/investing/2024/01/20/will-eli-lilly-be-worth-more-than-meta-platforms/",
            "time_published": "20240120T144500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "It would be quite the accomplishment for the drugmaker.",
            "banner_image": "https://media.ycharts.com/charts/46557cd62ae4e92e49f1f7c9ac145684.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.183138,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.70749",
                    "ticker_sentiment_score": "0.240222",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.642977",
                    "ticker_sentiment_score": "0.280435",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 High-Flying Stocks That Could Soar Even More in 2024",
            "url": "https://www.fool.com/investing/2024/01/20/3-high-flying-stocks-that-could-soar-even-more-in/",
            "time_published": "20240120T115000",
            "authors": [
                "David Jagielski",
                "Keith Speights",
                "and Prosper Junior Bakiny"
            ],
            "summary": "These big winners could keep the momentum going.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761822/dna-on-monitor-scientists.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.284698,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.260652",
                    "ticker_sentiment_score": "0.195213",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "0.26179",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "0.056817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.30211",
                    "ticker_sentiment_score": "0.160317",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "-0.005924",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Healthcare Giant Eli Lilly Under FDA Lens Again For Manufacturing Lapses - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36699634/healthcare-giant-eli-lilly-under-fda-lens-again-for-manufacturing-lapses",
            "time_published": "20240119T182152",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY faces renewed scrutiny as the FDA inspectors reveal additional manufacturing issues at its Branchburg, New Jersey plant. In a recent inspection conducted by the FDA in July, eight deficiencies were identified, ranging from problems in tracking the manufacturing process to ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Eli-Lilly.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.110724,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.568148",
                    "ticker_sentiment_score": "0.072943",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Eli Lilly, Linde, NextEra Energy, Honda Motor, Arthur J. Gallagher and Block",
            "url": "https://www.zacks.com/stock/news/2212548/the-zacks-analyst-blog-highlights-eli-lilly-linde-nextera-energy-honda-motor-arthur-j-gallagher-and-block",
            "time_published": "20240119T094000",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Eli Lilly, Linde, NextEra Energy, Honda Motor, Arthur J. Gallagher and Block are included in this Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.183774,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LIN",
                    "relevance_score": "0.413425",
                    "ticker_sentiment_score": "0.322251",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.349575",
                    "ticker_sentiment_score": "0.168288",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SQ",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.034497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HMC",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.034497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.349575",
                    "ticker_sentiment_score": "0.159724",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Tumbled on Thursday",
            "url": "https://www.fool.com/investing/2024/01/18/why-eli-lilly-stock-tumbled-on-thursday/",
            "time_published": "20240118T233601",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "Investors were a bit concerned about an industrywide move.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761845/medical-professionals-conferring-in-a-hospial-corridor.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.109739,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.428632",
                    "ticker_sentiment_score": "0.07204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "0.16529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Top Analyst Reports for Eli Lilly, Linde & NextEra Energy",
            "url": "https://www.zacks.com/research-daily/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy",
            "time_published": "20240118T174200",
            "authors": [
                "Sheraz Mian"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE).",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.229808,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LIN",
                    "relevance_score": "0.30569",
                    "ticker_sentiment_score": "0.498644",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.206685",
                    "ticker_sentiment_score": "0.280479",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.206685",
                    "ticker_sentiment_score": "0.209828",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly  ( LLY )  Dipped More Than Broader Market Today",
            "url": "https://www.zacks.com/stock/news/2211728/why-eli-lilly-lly-dipped-more-than-broader-market-today",
            "time_published": "20240117T224517",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) reachead $628.91 at the closing of the latest trading day, reflecting a -0.89% change compared to its last close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default101.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.983783"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.210888,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.558244",
                    "ticker_sentiment_score": "0.26377",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Balancing Act: The Ultimate Guide To Large-Cap Growth Stocks With Low Risk - Apple  ( NASDAQ:AAPL ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/24/01/36663650/balancing-act-the-ultimate-guide-to-large-cap-growth-stocks-with-low-risk",
            "time_published": "20240117T164342",
            "authors": [
                "Aditi Ganguly"
            ],
            "summary": "The stock market has rebounded from a weak start to the year, with the benchmark S&P 500 index rising by over 1.8% over the past five days. The tech-focused Nasdaq Composite Index has fared better as the tech rally resumes momentum, gaining over 3% in the second trading week of 2024.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Middle-Aged-Hispanic-Business-Manager-Ce.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998962"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.992549"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.202814,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.176502",
                    "ticker_sentiment_score": "-0.00436",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.21961",
                    "ticker_sentiment_score": "0.067022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.21961",
                    "ticker_sentiment_score": "0.434536",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.053643",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly's Blockbuster Diabetes Drug Mounjaro Set To Enter New Markets Amid Manufacturing Boost - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36662189/eli-lillys-blockbuster-diabetes-drug-mounjaro-set-to-enter-new-markets-amid-manufacturing-boost",
            "time_published": "20240117T153050",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly & Company LLY has unveiled plans to introduce its weight-loss drug Mounjaro ( tirzepatide ) in new countries this year while simultaneously expanding manufacturing capacity,",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.110028,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.772528",
                    "ticker_sentiment_score": "0.082062",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?",
            "url": "https://www.zacks.com/stock/news/2211196/should-you-invest-in-the-vanguard-health-care-etf-vht",
            "time_published": "20240117T112007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default100.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.232494,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.064698",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.125875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.064698",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.064698",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bull of the Day: Regeneron Pharmaceuticals  ( REGN ) ",
            "url": "https://www.zacks.com/commentary/2211051/bull-of-the-day-regeneron-pharmaceuticals-regn",
            "time_published": "20240117T093000",
            "authors": [
                "Ethan Feller"
            ],
            "summary": "The Biotechnology company enjoys a litany of bullish catalysts on the horizon ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default21.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.839681"
                }
            ],
            "overall_sentiment_score": 0.242725,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.20698",
                    "ticker_sentiment_score": "0.072522",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.20698",
                    "ticker_sentiment_score": "0.231906",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.20698",
                    "ticker_sentiment_score": "0.072522",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Zacks Investment Ideas feature highlights: Eli Lilly and Novartis",
            "url": "https://www.zacks.com/stock/news/2211164/zacks-investment-ideas-feature-highlights-eli-lilly-and-novartis",
            "time_published": "20240117T084300",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Eli Lilly and Novartis have been highlighted in this Investment Ideas article.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.229073,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.158173",
                    "ticker_sentiment_score": "0.167993",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Disney board nominates slate of dozen directors that excludes activist investors",
            "url": "https://www.marketwatch.com/story/disney-board-nominates-dozen-nominees-that-does-not-include-activist-investors-ca209b34",
            "time_published": "20240116T232200",
            "authors": [
                "Jon Swartz"
            ],
            "summary": "Walt Disney Co.'s board on Tuesday nominated a slate of 12 directors that notably left out activist investors from Trian Fund Management ( Nelson Peltz, James Rasulo ) and Blackwells Group ( Craig Hatkoff, Jessica Schell, Leah Solivan ) , both of which have been highly critical of Disney Chief ...",
            "banner_image": "https://images.mktw.net/im-76764933/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": -0.018947,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.419153",
                    "ticker_sentiment_score": "-0.059125",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.026743",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "-0.044416",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Unpacking the Latest Options Trading Trends in Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/24/01/36647588/unpacking-the-latest-options-trading-trends-in-eli-lilly",
            "time_published": "20240116T183219",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.104602,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.651499",
                    "ticker_sentiment_score": "0.077542",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High",
            "url": "https://www.zacks.com/commentary/2211005/these-stocks-are-showing-relative-strength-as-sp-500-stalls-near-record-high",
            "time_published": "20240116T174900",
            "authors": [
                "Bryan Hayes"
            ],
            "summary": "As investors, our job isn't to predict an unknowable future.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/charts/06/59517.png?v=596080559",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.22225,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.168458",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Charts turn bullish on health-care stocks as sector takes early lead in 2024",
            "url": "https://www.marketwatch.com/story/charts-turn-bullish-on-health-care-stocks-as-sector-takes-early-lead-in-2024-12272495",
            "time_published": "20240116T162900",
            "authors": [
                "Joseph Adinolfi"
            ],
            "summary": "Health-care stocks are off to a strong start in 2024, and Wall Street analysts are taking notice.",
            "banner_image": "https://images.mktw.net/im-735118/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.342773,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MCK",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.294849",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.15697",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know",
            "url": "https://www.zacks.com/stock/news/2210683/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know",
            "time_published": "20240116T140011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default227.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.235186,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.529767",
                    "ticker_sentiment_score": "0.170174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Futures Fall; Elon Musk Makes This Tesla Threat",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-boeing-apple-in-focus-elon-musk-makes-this-tesla-threat/",
            "time_published": "20240115T234000",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Futures Fall. Elon Musk Makes This Tesla Threat Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/05/Stock-elonmusk-grumpy-01-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.016993,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.349803",
                    "ticker_sentiment_score": "0.12775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.165788",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.246444",
                    "ticker_sentiment_score": "0.21025",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "-0.018659",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.349803",
                    "ticker_sentiment_score": "-0.165023",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "0.072576",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.13589",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.027828",
                    "ticker_sentiment_score": "-0.054775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.053346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "-0.093256",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These 2 Top Healthcare Stocks Declared Dividend Raises in 2023",
            "url": "https://www.fool.com/investing/2024/01/15/these-2-top-healthcare-stocks-declared-dividend-ra/",
            "time_published": "20240115T114600",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "For different reasons, both Eli Lilly and UnitedHealth are doing well enough to enact substantial dividend raises.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760775/medical-professionals-conferring-in-a-hospial-corridor.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.200385,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.290262",
                    "ticker_sentiment_score": "0.153969",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.059341",
                    "ticker_sentiment_score": "0.132101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.234119",
                    "ticker_sentiment_score": "0.150481",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca",
            "url": "https://www.zacks.com/stock/news/2209905/the-zacks-analyst-blog-highlights-eli-lilly-novo-nordisk-amgen-and-astrazeneca",
            "time_published": "20240115T105000",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Eli Lilly, Novo Nordisk, Amgen and AstraZeneca are included in this Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.094253,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.261117",
                    "ticker_sentiment_score": "0.085906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.261117",
                    "ticker_sentiment_score": "0.040358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.07059",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.053153",
                    "ticker_sentiment_score": "0.149079",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.261117",
                    "ticker_sentiment_score": "0.241559",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Futures Fall: Market Rally Stellar; Four Stocks In Buy Zones",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-stellar-market-rally/",
            "time_published": "20240114T231900",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Futures Fall: Market Rally Stellar. Four Stocks In Buy Zones Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/07/stock-bull-charge-02-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.053334,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.404312",
                    "ticker_sentiment_score": "0.14192",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.28664",
                    "ticker_sentiment_score": "0.236438",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.090714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "-0.156739",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.079619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "0.136213",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.032558",
                    "ticker_sentiment_score": "-0.056152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "0.054082",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.065061",
                    "ticker_sentiment_score": "-0.086608",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These 9 Stocks Are Running To Start 2024",
            "url": "https://www.investors.com/news/sp-500-these-9-stocks-are-running-to-start-2024/",
            "time_published": "20240114T130000",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "The S&P 500 index is up just a fraction in 2024 so far, but a number of big caps are off to a strong start. Nvidia ( NVDA ) , the No. 1 S&P 500 stock performer in 2023, is leading the way again. That is, excluding Juniper Networks ( JNPR ) , which spiked last week as Hewlett Packard Enterprise ( ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/05/Stock-nvidia-hq-01-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.172108,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.500753",
                    "ticker_sentiment_score": "0.177567",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.31482",
                    "ticker_sentiment_score": "0.109733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNPR",
                    "relevance_score": "0.160633",
                    "ticker_sentiment_score": "0.128431",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.213048",
                    "ticker_sentiment_score": "0.149398",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.264515",
                    "ticker_sentiment_score": "0.098631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.05387",
                    "ticker_sentiment_score": "0.096737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.31482",
                    "ticker_sentiment_score": "0.107239",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPE",
                    "relevance_score": "0.107495",
                    "ticker_sentiment_score": "0.105371",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.31482",
                    "ticker_sentiment_score": "0.246327",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.213048",
                    "ticker_sentiment_score": "0.028285",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024",
            "url": "https://www.fool.com/investing/2024/01/14/move-over-novo-nordisk-this-is-the-pharmaceutical/",
            "time_published": "20240114T114500",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Novo Nordisk may dominate the weight management space, but pharma giant Eli Lilly is quickly gaining steam.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760470%2Fbreast-cancer-awareness-doctor.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.210943,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.436009",
                    "ticker_sentiment_score": "0.40443",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.436009",
                    "ticker_sentiment_score": "0.315391",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong",
            "url": "https://www.fool.com/investing/2024/01/13/after-surging-53-in-2023-this-pharmaceutical-stock/",
            "time_published": "20240113T153000",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "The rise of Ozempic and Wegovy helped Novo Nordisk stock surge over 50% last year.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760592%2Fblood-pressure-doctor-senior-citizen.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.200507,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.245835",
                    "ticker_sentiment_score": "0.111819",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.584467",
                    "ticker_sentiment_score": "0.200302",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Unstoppable Stocks to Buy in 2024",
            "url": "https://www.fool.com/investing/2024/01/13/3-unstoppable-stocks-to-buy-in-2024/",
            "time_published": "20240113T124800",
            "authors": [
                "Keith Speights",
                "David Jagielski",
                "and Prosper Junior Bakiny"
            ],
            "summary": "These stocks appear to be on a clear path to continued growth.",
            "banner_image": "https://g.foolcdn.com/editorial/images/761021/scientists-in-a-lab-smiling.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.25543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.266343",
                    "ticker_sentiment_score": "0.049266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.349945",
                    "ticker_sentiment_score": "0.133208",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.143626",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.308614",
                    "ticker_sentiment_score": "0.308668",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:DKK",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.270178",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:NOK",
                    "relevance_score": "0.045224",
                    "ticker_sentiment_score": "0.270178",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Market Making All The Right Moves; 4 Stocks In Buy Zones",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-making-the-right-moves-nvidia-microsoft-lead-tesla-breaks-down/",
            "time_published": "20240112T221400",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures: Market Rally Making The Right Moves. Nvidia, Microsoft Lead, Tesla Breaks Down Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/07/stock-bull-charge-02-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.057794,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.355588",
                    "ticker_sentiment_score": "0.081902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.212248",
                    "ticker_sentiment_score": "0.143681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.070598",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.241684",
                    "ticker_sentiment_score": "-0.1804",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.212248",
                    "ticker_sentiment_score": "0.119715",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.126024",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.03068",
                    "ticker_sentiment_score": "-0.011302",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.071779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "-0.086306",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Two Health Care Leaders Scale New Highs On Big Wins",
            "url": "https://www.investors.com/stock-lists/new-highs/lly-stock-is-at-a-new-high-after-a-new-website-launch/",
            "time_published": "20240112T204900",
            "authors": [
                "Investor's Business Daily",
                "VIDYA RAMAKRISHNAN"
            ],
            "summary": "LLY stock is at a high after a website launch Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/Stock-EliLilly-01-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                }
            ],
            "overall_sentiment_score": 0.232753,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.645887",
                    "ticker_sentiment_score": "0.223424",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.645887",
                    "ticker_sentiment_score": "0.255609",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns - Biogen  ( NASDAQ:BIIB ) ",
            "url": "https://www.benzinga.com/news/24/01/36615264/evolving-landscape-for-alzheimers-blood-tests-gains-momentum-amid-inaccuracy-concerns",
            "time_published": "20240112T181714",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "A new era in Alzheimer's diagnosis is on the horizon as Dr. Suzanne Schindler and her team at Washington University School of Medicine pioneered blood tests capable of detecting sticky amyloid plaques, a key Alzheimer's indicator.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/dementia-Photo-by-Gerd-Altmann-via-Pixab.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.0975,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.155954",
                    "ticker_sentiment_score": "0.144892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DGX",
                    "relevance_score": "0.155954",
                    "ticker_sentiment_score": "0.096036",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LH",
                    "relevance_score": "0.155954",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.193429",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.155954",
                    "ticker_sentiment_score": "0.252164",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts",
            "url": "https://www.zacks.com/stock/news/2209351/fda-finds-no-link-between-obesity-drugs-and-suicidal-thoughts",
            "time_published": "20240112T124700",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases and is gaining significant popularity.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/82/41137.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.101797,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.227007",
                    "ticker_sentiment_score": "0.104048",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.227007",
                    "ticker_sentiment_score": "0.056869",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.171282",
                    "ticker_sentiment_score": "0.110461",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.149399",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.227007",
                    "ticker_sentiment_score": "0.250732",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/news/24/01/36602710/fda-finds-no-evidence-weight-loss-drugs-cause-suicidal-thoughts",
            "time_published": "20240111T215505",
            "authors": [
                "Erica Kollmann"
            ],
            "summary": "Following a preliminary review, the U.S. Food and Drug Administration found no evidence that weight-loss drugs cause suicidal thoughts.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/man-3011213-1280.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.117571,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "-0.071299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "-0.081664",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance - Amgen  ( NASDAQ:AMGN ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36594746/large-drugmakers-show-enthusiasm-to-embrace-100b-obesity-market-despite-novo-and-lillys-dominance",
            "time_published": "20240111T164037",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Pharmaceutical companies, including Amgen Inc AMGN and Pfizer Inc PFE, are strategically positioning themselves to tap into the burgeoning obesity market. The pursuit involves developing innovative drugs or engaging in strategic acquisitions to compete with established players such as Novo ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/11/aapharma_0.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.164763,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.228073",
                    "ticker_sentiment_score": "0.084786",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.252282",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.252282",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.228073",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.531326",
                    "ticker_sentiment_score": "0.077283",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.43789",
                    "ticker_sentiment_score": "0.185632",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "60% Of This Year's Top Stocks Are In This Sector  ( It's Not Tech ) ",
            "url": "https://www.investors.com/etfs-and-funds/etfs/sp500-this-years-top-stocks-are-in-this-sector-not-tech/",
            "time_published": "20240111T130000",
            "authors": [
                "Investor's Business Daily",
                "MATT KRANTZ"
            ],
            "summary": "Just when it looked like technology stocks took over the S&P 500 - another sector is on the rise. Health care stocks, like Viatris ( VTRS ) , Catalent ( CTLT ) and Moderna ( MRNA ) , are dominating the ranks of top-performing stocks this year so far, says an Investor's Business Daily analysis of ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/11/Stock-doctormoney-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99246"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.242038,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNPR",
                    "relevance_score": "0.123209",
                    "ticker_sentiment_score": "0.074964",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.123209",
                    "ticker_sentiment_score": "0.192664",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.243498",
                    "ticker_sentiment_score": "0.201769",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.183895",
                    "ticker_sentiment_score": "0.180302",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.164515",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.183895",
                    "ticker_sentiment_score": "0.111881",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.123209",
                    "ticker_sentiment_score": "0.141481",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Skyrocketed 59% in 2023",
            "url": "https://www.fool.com/investing/2024/01/11/why-eli-lilly-stock-skyrocketed-59-in-2023/",
            "time_published": "20240111T104900",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Lilly's pipeline success in 2023 allowed it to to claim the crown as the biggest drugmaker on the planet by market cap.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760865/scientists-smiling-and-shaking-hands.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.857896"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.163735,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.722311",
                    "ticker_sentiment_score": "0.243335",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.078611",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078611",
                    "ticker_sentiment_score": "0.155496",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly  ( LLY )  Outpaced the Stock Market Today",
            "url": "https://www.zacks.com/stock/news/2208495/why-eli-lilly-lly-outpaced-the-stock-market-today",
            "time_published": "20240110T224520",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) closed the most recent trading day at $630.19, moving +0.75% from the previous trading session.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default327.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.252041,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.673811",
                    "ticker_sentiment_score": "0.351443",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly's Options: A Look at What the Big Money is Thinking - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/24/01/36581006/eli-lillys-options-a-look-at-what-the-big-money-is-thinking",
            "time_published": "20240110T174609",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 50 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.085924,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.645091",
                    "ticker_sentiment_score": "-0.113283",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What is Wegovy worth to your employer? Companies wrestle with obesity drugs' costs, long-term value.",
            "url": "https://www.marketwatch.com/story/what-is-wegovy-worth-to-your-employer-companies-wrestle-with-obesity-drugs-costs-long-term-value-520b37c4",
            "time_published": "20240110T140000",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Amid mounting evidence of obesity drugs' long-term health benefits, thorny questions persist about their value to employers ...",
            "banner_image": "https://images.mktw.net/im-520633/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.138036,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.16144",
                    "ticker_sentiment_score": "0.102609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.201021",
                    "ticker_sentiment_score": "0.163011",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36572555/bring-on-the-competition-in-obesity-drugs-novo-nordisk-ceo-optimistic-about-prolonged-patient-adh",
            "time_published": "20240110T114313",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Lars Fruergaard Jorgensen, CEO of Novo Nordisk A/S NVO, shared insights during the JPMorgan Healthcare conference, highlighting Wegovy's efficacy for weight loss, indicating that patients are likely to continue with Wegovy for more extended periods compared to older treatments commonly used.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/wegovy-company.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.266805,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.342487",
                    "ticker_sentiment_score": "0.044989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.117486",
                    "ticker_sentiment_score": "0.002294",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.445569",
                    "ticker_sentiment_score": "0.124314",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wall Street Doesn't Expect Eli Lilly Stock to Move Much Higher in 2024. Here's Why Analysts Could Be Wrong.",
            "url": "https://www.fool.com/investing/2024/01/10/wall-street-doesnt-expect-eli-lilly-stock-to-move/",
            "time_published": "20240110T105100",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Lilly's sizzle might not fizzle in the new year.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760650/stock-charts-on-screen-analysts.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.164182,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.759979",
                    "ticker_sentiment_score": "0.161885",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062434",
                    "ticker_sentiment_score": "0.020019",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Biotech ETFs Stage Solid Comeback at the Start of 2024",
            "url": "https://www.zacks.com/stock/news/2207551/biotech-etfs-stage-solid-comeback-at-the-start-of-2024",
            "time_published": "20240109T160500",
            "authors": [
                "Sweta Killa"
            ],
            "summary": "The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.147642,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.162037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.084886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.084886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.06769",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRCL",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.058856",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HARP",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.084886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.162037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.133346",
                    "ticker_sentiment_score": "0.071668",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.140918",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Simple Tricks That Every Investor Should Use  ( but Most Don't ) ",
            "url": "https://www.fool.com/investing/2024/01/09/3-simple-tricks-that-every-investor-should-use-but/",
            "time_published": "20240109T151500",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "Having a few tricks up your sleeve can increase your returns over time.",
            "banner_image": "https://media.ycharts.com/charts/48e06246cfdd0fa2187cc0683cfa221e.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                }
            ],
            "overall_sentiment_score": 0.233827,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "-0.026863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.128363",
                    "ticker_sentiment_score": "0.032509",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.085782",
                    "ticker_sentiment_score": "0.123385",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.170576",
                    "ticker_sentiment_score": "-0.026863",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles - Pfizer  ( NYSE:PFE ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36552329/pfizers-aggressive-stance-in-obesity-drugs-ceo-albert-bourla-confirms-bold-bet-despite-prior-drug",
            "time_published": "20240109T124231",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Monday, at the JP Morgan Healthcare Conference, Pfizer Inc PFE CEO Albert Bourla expressed that the company is determined to move forward in the burgeoning obesity market despite setbacks involving a terminated weight-loss drug candidate due to severe side effects.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/09/weight-loss-photo_by_vidmir_rais_via_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.014279,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.213048",
                    "ticker_sentiment_score": "0.089198",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.107495",
                    "ticker_sentiment_score": "-0.00444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.213048",
                    "ticker_sentiment_score": "0.089198",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.500753",
                    "ticker_sentiment_score": "0.056545",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How To Buy Hot And Promising - But Uncertain - Biotech Stocks",
            "url": "https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/xbi-etf-how-to-buy-hot-and-promising-but-uncertain-biotech-stocks/",
            "time_published": "20240108T173400",
            "authors": [
                "Investor's Business Daily",
                "MATTHEW GALGANI"
            ],
            "summary": "A mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. The SPDR S&P Biotech ETF ( XBI ) , now on the IBD Leaderboard watchlist, offers an alternative to betting on a single biotech name.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/Stock-petridishmolecule-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.268824,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.083541",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARWR",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.070153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.200529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.200529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.400052",
                    "ticker_sentiment_score": "0.433085",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.070153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.430266",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AAPL: Are AAPL, MSFT, and GOOGL Solid 2024 Buys?",
            "url": "https://stocknews.com/news/aapl-msft-googl-lly-nvs-are-aapl-msft-and-googl-solid-2024-buys/",
            "time_published": "20240108T162405",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The Magnificent Seven stocks, which include Apple Inc. ( AAPL ) , Microsoft Corporation ( MSFT ) and Alphabet Inc. ( GOOGL ) , concluded a stellar year, outperforming the S&P 500 index. Vanguard Mega Cap Growth Index Fund ETF Shares ( MGK ) secured a 6.9% gain over the past six months, surpassing ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999365"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999982"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.355517,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.051441",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.301315",
                    "ticker_sentiment_score": "0.420556",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.077094",
                    "ticker_sentiment_score": "0.20494",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.178648",
                    "ticker_sentiment_score": "0.356535",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.051441",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.025734",
                    "ticker_sentiment_score": "0.060904",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Fall As Boeing Tumbles",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-boeing-plunges-on-737-max-woes-can-market-rally-hold-key-levels/",
            "time_published": "20240108T112800",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures Fall As Boeing Plunges On 737 Max Woes. Can Market Rally Hold Key Levels? Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2016/02/Biz05-airshow-022216-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.026516,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALK",
                    "relevance_score": "0.073849",
                    "ticker_sentiment_score": "-0.059431",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MARA",
                    "relevance_score": "0.073849",
                    "ticker_sentiment_score": "-0.097112",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.024648",
                    "ticker_sentiment_score": "-0.137676",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.289178",
                    "ticker_sentiment_score": "0.02146",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.049271",
                    "ticker_sentiment_score": "0.05937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.024648",
                    "ticker_sentiment_score": "0.038323",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.049271",
                    "ticker_sentiment_score": "-0.094177",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.147066",
                    "ticker_sentiment_score": "0.049267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.073849",
                    "ticker_sentiment_score": "0.060439",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMCI",
                    "relevance_score": "0.073849",
                    "ticker_sentiment_score": "0.007117",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.049271",
                    "ticker_sentiment_score": "0.05937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.171224",
                    "ticker_sentiment_score": "-0.004301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHM",
                    "relevance_score": "0.122769",
                    "ticker_sentiment_score": "0.045676",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.171224",
                    "ticker_sentiment_score": "0.049832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.122769",
                    "ticker_sentiment_score": "-0.126965",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.195222",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alphabet Unit In Drug Discovery Deals With Eli Lilly, Novartis",
            "url": "https://www.investors.com/news/technology/alphabet-isomorphic-labs-in-drug-discovery-deals-with-eli-lilly-novartis/",
            "time_published": "20240107T202600",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Isomorphic Labs, a unit of Google-parent Alphabet ( GOOGL ) , on Sunday announced strategic research collaborations with Eli Lilly ( LLY ) and Novartis ( NVS ) . The Lilly and Novartis collaborations will focus on small-molecule treatments and multiple targets.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/01/Stock-AIbiotech-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                }
            ],
            "overall_sentiment_score": 0.103625,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.696319",
                    "ticker_sentiment_score": "0.241613",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.125025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.185545",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Market Rally At Key Level; Nvidia Leads 6 Stocks To Watch",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-at-key-levels-nvidia-leads-6-stocks-near-buy-points/",
            "time_published": "20240106T224600",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures: Market Rally At Key Levels. Nvidia Leads 6 Stocks Near Buy Points Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/03/Stock-nvidia-ceojensenhuang-01-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.055121,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALK",
                    "relevance_score": "0.02665",
                    "ticker_sentiment_score": "-0.050722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MARA",
                    "relevance_score": "0.079832",
                    "ticker_sentiment_score": "-0.040916",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.286741",
                    "ticker_sentiment_score": "0.002141",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "0.066721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.02665",
                    "ticker_sentiment_score": "0.038808",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "-0.094682",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.051729",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.079832",
                    "ticker_sentiment_score": "0.068036",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMCI",
                    "relevance_score": "0.079832",
                    "ticker_sentiment_score": "0.007196",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "0.066721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.184901",
                    "ticker_sentiment_score": "-0.004546",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHM",
                    "relevance_score": "0.13266",
                    "ticker_sentiment_score": "0.047474",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.080575",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "-0.060459",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.025606",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nvidia And Spotify Lead Five Stocks Near Buy Points",
            "url": "https://www.investors.com/news/nvidia-spotify-lead-five-stocks-near-buy-points/",
            "time_published": "20240106T161200",
            "authors": [
                "JED GRAHAM",
                "Investor's Business Daily"
            ],
            "summary": "Nvidia ( NVDA ) , one of the Magnificent Seven stocks, and digital audio streaming leader Spotify ( SPOT ) head this weekend's watchlist of stocks near buy points.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/05/Stock-nvidia-hq-04-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.818451"
                }
            ],
            "overall_sentiment_score": 0.141748,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TGT",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "0.173176",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CELH",
                    "relevance_score": "0.32231",
                    "ticker_sentiment_score": "0.198665",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.294446",
                    "ticker_sentiment_score": "0.241706",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ULTA",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "0.173176",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.03014",
                    "ticker_sentiment_score": "0.070517",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.03014",
                    "ticker_sentiment_score": "0.068427",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.34974",
                    "ticker_sentiment_score": "0.242228",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MNST",
                    "relevance_score": "0.090247",
                    "ticker_sentiment_score": "-0.130828",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.237551",
                    "ticker_sentiment_score": "0.119502",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "0.041072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "0.073016",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.060236",
                    "ticker_sentiment_score": "-0.004022",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Top Healthcare Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2024/01/06/2-top-healthcare-stocks-to-buy-right-now/",
            "time_published": "20240106T151500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "It's always a good time to invest in these excellent stocks.",
            "banner_image": "https://g.foolcdn.com/editorial/images/759940/patient-talking-with-a-physician.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.236189,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.322374",
                    "ticker_sentiment_score": "0.211863",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MFCSF",
                    "relevance_score": "0.110209",
                    "ticker_sentiment_score": "0.087754",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.055236",
                    "ticker_sentiment_score": "0.243008",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HCA",
                    "relevance_score": "0.51159",
                    "ticker_sentiment_score": "0.344214",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "JPMorgan Healthcare, CES Show, Bank Earnings, Inflation Data",
            "url": "https://www.investors.com/research/investing-action-plan/jpmorgan-healthcare-ces-show-bank-earnings-inflation-data-investing-action-plan/",
            "time_published": "20240105T222900",
            "authors": [
                "Investor's Business Daily",
                "IBD STAFF"
            ],
            "summary": "The big benchmarks launched the New Year by posting their first weekly slip since October. The Dow trimmed less than 1% while the Nasdaq lopped off 3%. Chips faltered, but solar stocks and auto retailers were the hardest hit industries. Big Pharma names had a good week, as Merck ( MRK ) led the ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/07/Stock-marketgrowth-03-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.173993,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CELH",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.144722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.144722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WDFC",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.013892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.021094",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WIT",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.064744",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.164188",
                    "ticker_sentiment_score": "0.1163",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.144722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.021094",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.144722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BK",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.018562",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.133922",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.018562",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KBH",
                    "relevance_score": "0.164188",
                    "ticker_sentiment_score": "0.107238",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AYI",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.091327",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.088799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.164188",
                    "ticker_sentiment_score": "0.024866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.164188",
                    "ticker_sentiment_score": "0.109444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BBY",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.088799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.133922",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INFY",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.064744",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.041323",
                    "ticker_sentiment_score": "0.084607",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.082535",
                    "ticker_sentiment_score": "0.088799",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Market At Key Levels, Here's What To Do; Nvidia Nears Breakout",
            "url": "https://www.investors.com/market-trend/stock-market-today/market-rally-at-key-levels-bitcoin-etf-nvidia-near-buy-point-on-100-billion-forecast/",
            "time_published": "20240105T221800",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Market At Key Levels, Here's What To Do. Nvidia Nears Breakout Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/03/Stock-nvidia-ceojensenhuang-01-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.05755,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MARA",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "-0.040301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.196725",
                    "ticker_sentiment_score": "-0.004762",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.278063",
                    "ticker_sentiment_score": "-0.031214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.056741",
                    "ticker_sentiment_score": "0.064925",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.028388",
                    "ticker_sentiment_score": "0.039211",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHM",
                    "relevance_score": "0.141227",
                    "ticker_sentiment_score": "0.049142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.056741",
                    "ticker_sentiment_score": "-0.094929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.053951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.066588",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMCI",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.007278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.084005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.056741",
                    "ticker_sentiment_score": "0.064925",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "0.026688",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "IBD Stock Of The Day: The Buying Opportunity In Weight Loss",
            "url": "https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-lingers-in-a-buy-zone-after-snagging-two-obesity-deals/",
            "time_published": "20240105T180100",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "Novo Nordisk Stock Lingers In Buy Zone After Snagging Two Obesity Deals Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/SOTD-1-4-2024NVO.png",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999365"
                }
            ],
            "overall_sentiment_score": 0.130124,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.404098",
                    "ticker_sentiment_score": "0.232614",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.350564",
                    "ticker_sentiment_score": "0.141762",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.032569",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.032569",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.106572",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.032569",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "0.337437",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Omega  ( OMGA )  Up 95% on Obesity Drug Deal With Novo Nordisk",
            "url": "https://www.zacks.com/stock/news/2206517/omega-omga-up-95-on-obesity-drug-deal-with-novo-nordisk",
            "time_published": "20240105T175500",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Using Omega's (OMGA) proprietary technology platform, Novo Nordisk (NVO) intends to develop a novel therapeutic for obesity, which will enhance the body's metabolism activity to burn excess fats.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.249163,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.171282",
                    "ticker_sentiment_score": "0.181114",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.171282",
                    "ticker_sentiment_score": "0.135412",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.334762",
                    "ticker_sentiment_score": "0.156185",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.436009",
                    "ticker_sentiment_score": "0.356733",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Weight-Loss Drug Boom: Philanthropy Powerhouse Emerges As Lilly Endowment Comes Closer To Gates Foundation - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/24/01/36514235/weight-loss-drug-boom-philanthropy-powerhouse-emerges-as-lilly-endowment-comes-closer-to-gates-fo",
            "time_published": "20240105T175137",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "The Lilly Endowment, the principal stakeholder in pharmaceutical giant Eli Lilly & Co. LLY, has witnessed an exceptional surge in its assets, reaching an estimated $60 billion amid the soaring success of the company's weight-loss drug, Mounjaro, which bolstered Eli Lilly's stocks by almost 60% ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Ozempic-and-other-drugs-for-weight-loss.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.210521,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.868543",
                    "ticker_sentiment_score": "0.34658",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stock Market Skids To Start 2024: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-skids-to-start-2024-as-tesla-apple-stumble-mobileye-crashes-weekly-review/",
            "time_published": "20240105T172600",
            "authors": [
                "IBD STAFF",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/03/Stock-BullBearMarket-88-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.004903,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MARA",
                    "relevance_score": "0.122425",
                    "ticker_sentiment_score": "0.031073",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XPEV",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "0.043033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.182736",
                    "ticker_sentiment_score": "-0.254609",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "ADI",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "-0.10812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "0.097219",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.122425",
                    "ticker_sentiment_score": "-0.020511",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NXPI",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "-0.10812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAG",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "-0.048948",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.03072",
                    "ticker_sentiment_score": "0.092757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LW",
                    "relevance_score": "0.091977",
                    "ticker_sentiment_score": "-0.053265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "-0.10812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STM",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "-0.10812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.122425",
                    "ticker_sentiment_score": "0.031073",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMPL",
                    "relevance_score": "0.091977",
                    "ticker_sentiment_score": "-0.053265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.03072",
                    "ticker_sentiment_score": "-0.282869",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.212514",
                    "ticker_sentiment_score": "0.010321",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NIO",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "0.043033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.182736",
                    "ticker_sentiment_score": "-0.026343",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPE",
                    "relevance_score": "0.091977",
                    "ticker_sentiment_score": "-0.085615",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LI",
                    "relevance_score": "0.122425",
                    "ticker_sentiment_score": "-0.019092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.061394",
                    "ticker_sentiment_score": "0.036136",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.122425",
                    "ticker_sentiment_score": "0.031073",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dry January Investing: Trading Pints For Portfolio Growth - Merck & Co  ( NYSE:MRK ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/equities/24/01/36513620/dry-january-investing-trading-pints-for-portfolio-growth",
            "time_published": "20240105T172022",
            "authors": [
                "Neil Dennis"
            ],
            "summary": "Around 15% of Americans said they were planning to participate this year in Dry January - a month of abstinence from alcohol - according to a survey by Morning Consult. Most cite the health benefits from taking a break from the bottle, but it has its financial benefits too.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/wall-street-beer-shutter.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.214335,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.294132",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "STZ",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.072032",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAP",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.072032",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.339557",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.115142",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NVS or LLY: Which Is the Better Value Stock Right Now?",
            "url": "https://www.zacks.com/stock/news/2206412/nvs-or-lly-which-is-the-better-value-stock-right-now",
            "time_published": "20240105T164006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "NVS vs. LLY: Which Stock Is the Better Value Option?",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default15.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.504108,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.622414",
                    "ticker_sentiment_score": "0.51906",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Lilly  ( LLY )  Starts Website to Help Access Tirzepatide Drugs",
            "url": "https://www.zacks.com/stock/news/2206369/lilly-lly-starts-website-to-help-access-tirzepatide-drugs",
            "time_published": "20240105T153600",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly's (LLY) digital pharmacy is expected to provide patients easy access to its FDA-approved tirzepatide medicines, Mounjaro and Zepbound.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.203265,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.510838",
                    "ticker_sentiment_score": "0.022707",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LFMD",
                    "relevance_score": "0.204647",
                    "ticker_sentiment_score": "0.052019",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HIMS",
                    "relevance_score": "0.270523",
                    "ticker_sentiment_score": "0.064996",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.207108",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.137278",
                    "ticker_sentiment_score": "0.300003",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Novo Nordisk  ( NVO )  Up on $1.1B Research Deals With 2 Biotechs",
            "url": "https://www.zacks.com/stock/news/2206370/novo-nordisk-nvo-up-on-11b-research-deals-with-2-biotechs",
            "time_published": "20240105T153500",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Novo Nordisk (NVO) gains 4% after signing $1.1 billion research collaboration agreements with two biotech companies to develop novel treatment approaches for cardiometabolic diseases.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.228746,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.164749",
                    "ticker_sentiment_score": "0.15357",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.244928",
                    "ticker_sentiment_score": "0.091398",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.322549",
                    "ticker_sentiment_score": "0.162148",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.467318",
                    "ticker_sentiment_score": "0.323723",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals",
            "url": "https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-llys-new-digital-pharmacy-nvo-abbvs-fresh-rd-deals",
            "time_published": "20240105T152500",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/88/898.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.143344,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.295867",
                    "ticker_sentiment_score": "0.076649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.295867",
                    "ticker_sentiment_score": "0.240803",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.199859",
                    "ticker_sentiment_score": "0.154026",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.295867",
                    "ticker_sentiment_score": "0.125188",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.050465",
                    "ticker_sentiment_score": "-0.119302",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Short Sellers' Nightmare: $195B Evaporates In 2023's Market Surge - Apple  ( NASDAQ:AAPL ) , Coinbase Glb  ( NASDAQ:COIN ) ",
            "url": "https://www.benzinga.com/markets/equities/24/01/36510120/short-sellers-nightmare-195b-evaporates-in-2023s-market-surge",
            "time_published": "20240105T142522",
            "authors": [
                "Neil Dennis"
            ],
            "summary": "In a year when equity markets rallied strongly, short sellers - traders who position for losses on assets - had an extremely tough time in 2023. Data published on Friday by S3 Partners showed that short sellers in the U.S. and Canada were down $194.9 billion in 2023 - down 20.4% on an average ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/bear-chart-shutter3.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99246"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.019588,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.042676",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.435133",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.042676",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.289687",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FRC",
                    "relevance_score": "0.094762",
                    "ticker_sentiment_score": "-0.272366",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.042676",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "It's Been An Abysmal Two Years. But Biotech Is Looking Up.",
            "url": "https://www.investors.com/news/technology/biotech-stocks-pharma-heat-up-in-2024-as-buyouts-obesity-ai-drive-excitement/",
            "time_published": "20240105T140000",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/A1-010824-biotech-Gash.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.12567,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.035679",
                    "ticker_sentiment_score": "0.069333",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NBIX",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.14181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.035679",
                    "ticker_sentiment_score": "0.037838",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IONS",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.084592",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARWR",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALEC",
                    "relevance_score": "0.09495",
                    "ticker_sentiment_score": "0.150269",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.153696",
                    "ticker_sentiment_score": "0.053027",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VERV",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.006781",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMGA",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.079056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NTLA",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "-0.008781",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHVN",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "-0.001871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.067127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.035679",
                    "ticker_sentiment_score": "0.017905",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPRX",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.14181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BEAM",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.057997",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRCL",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLNN",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "-0.020246",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.035679",
                    "ticker_sentiment_score": "0.08972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMPH",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.14181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARGX",
                    "relevance_score": "0.011896",
                    "ticker_sentiment_score": "-0.115274",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "0.067127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.02379",
                    "ticker_sentiment_score": "-0.042606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.035679",
                    "ticker_sentiment_score": "0.064761",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.059429",
                    "ticker_sentiment_score": "0.106048",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "7 Stocks Are Taking Off Already - And The Year Just Started",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-are-taking-off-already-and-the-year-just-started/",
            "time_published": "20240105T130000",
            "authors": [
                "MATT KRANTZ",
                "Investor's Business Daily"
            ],
            "summary": "The calendar just flipped to 2024 - and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated in 2023.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-cranesmoney-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.227189,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.276909",
                    "ticker_sentiment_score": "0.332128",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.521465",
                    "ticker_sentiment_score": "0.232629",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.09402",
                    "ticker_sentiment_score": "0.162601",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "QS, PTON, LLY, WBA, TSLA: Top 5 Trending Stocks Today - Peloton Interactive  ( NASDAQ:PTON ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/equities/24/01/36503974/quantumscape-peloton-eli-lilly-walgreens-tesla-why-these-5-stocks-are-on-investors-radars-today",
            "time_published": "20240105T015754",
            "authors": [
                "Benzinga Neuro"
            ],
            "summary": "U.S. stock markets gave a mixed picture on Thursday with the Dow Jones inching up 0.03% to 37,440.34. The S&P 500 and Nasdaq fell 0.34% and 0.56% to 4,688.68 and 14,510.30 respectively. These are the top stocks that gained the attention of retail traders and investors throughout the day:",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Stocks-Photo-by-Phongphan-on-Shutterstoc_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.2372,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.213988",
                    "ticker_sentiment_score": "-0.106164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSTK",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QS",
                    "relevance_score": "0.213988",
                    "ticker_sentiment_score": "0.301866",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.213988",
                    "ticker_sentiment_score": "0.35905",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PTON",
                    "relevance_score": "0.213988",
                    "ticker_sentiment_score": "0.271955",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.213988",
                    "ticker_sentiment_score": "0.089775",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}